Senti Biosciences, Inc. revenue breakdown overview

Senti Biosciences, Inc. revenue for the last year amounted to 2.56 M USD, the most of which — 2.56 M USD — came from its highest performing source at the moment, Next-generation Cell and Gene Therapies, the year earlier bringing 4.29 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Senti Biosciences, Inc. 2.56 M USD, and the year before that — 4.29 M USD.